Palo Alto, United States
ShangBay Capital is a venture capital company that brings both U.S. and global investors access to best-in-class investments in the U.S. medical devices, biotechnology, and digital health sectors through early-stage venture equity participation. Since our establishment in 2015, we have invested in over 50+ portfolio companies and have been ranked as the Most Active Medical Device VC across both the U.S. and Europe in 2020 and 2021.
28
Total Investments
24
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About ShangBay Capital
Recent Investments (28)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Mar 2025 | |
| Series B | •••••• | Nov 2024 | |
| Series C | •••••• | Feb 2024 | |
| Series A | •••••• | Jun 2023 | |
| Series C | •••••• | Jun 2023 | |
•••• ••••
|
Series A | •••••• | Jun 2023 |
|
•••• ••••
|
Series B | •••••• | Mar 2023 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Series A | •••••• | Jan 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
